COLO B Coloplast A/S Class B

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Please see enclosed pdf.



 

Attachment



EN
11/12/2024

Underlying

COLO BColoplast A/S Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
COLO B COLOPLAST A/S CLASS B
01/13/25 January 13, 2025 1 EN
Free Trial
COLO B Coloplast A/S C...

Coloplast AS: 1 director

A director at Coloplast AS bought 23,700 shares at 845.850DKK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

COLO B COLOPLAST A/S CLASS B
12/11/24 December 11, 2024 1 EN
 PRESS RELEASE
Free
COLO B Coloplast A/S C...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

December 11, 2024 1 EN
 PRESS RELEASE
Free
COLO B Coloplast A/S C...

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

December 11, 2024 1 EN
 PRESS RELEASE
Free
COLO B Coloplast A/S C...

Coloplast A/S - Beslutninger på den ordinære Generalforsamling 2024

Coloplast A/S - Beslutninger på den ordinære Generalforsamling 2024 I dag, den 5. december 2024, har Coloplast A/S afholdt ordinær generalforsamling, hvor følgende beslutninger blev vedtaget: Årsrapporten for regnskabsåret 2023/24 blev godkendt.Forslag om udbetaling af ordinært udbytte på 17,00 kr. pr. aktie á nominelt 1 kr. blev godkendt. I tillæg til de 5,00 kr. pr. aktie á nominelt 1 kr. udbetalt i forbindelse med halvårsresultatet, vil der således være udbetalt udbytte for regnskabsåret 2023/24 på samlet 22,00 kr. pr. aktie á nominelt 1 kr.Vederlagsrapporten for regnskabsåret 2023/...

December 5, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch